Lam S K
Department of Medicine, University of Hong Kong, Queen Mary Hospital.
Gastroenterol Jpn. 1993 May;28 Suppl 5:145-57. doi: 10.1007/BF02989226.
At the turn of the century, duodenal ulcer rose from rarity to affect 10% of males in their life time, subsequently declining in some countries such as UK, levelling off in others such as Germany, and continuing to increase in still others such as Hong Kong. The annual incidence per 1000 population varies from about 1 in Japan to 1.5 in Norway, 1.8 in USA and 2.7 in Scotland, and the frequency also varies within many individual countries, such as Australia, China and India, and among races such as a higher prevalence among whites than blacks in USA and among Chinese than Javanese in Indonesia. Ulcer frequency is higher in winter months, and this appears universal, being true in cold as well as in warm countries. Most places report a rise of ulcer rates among the elderly in recent decades. The male to female ratio also varies geographically, for example from 1:1 in USA to 18:1 in India, and with time such as moving from 2:1 to 1:1 in the last two decades in USA, and the duodenal ulcer to gastric ulcer ratio varies widely from place to place, for example from 0.8 in Japan to 19:1 in Africa and 32:1 in India. Placebo healing rates also differ geographically, ranging from 5% in Philippines to 78% in Mexico. These epidemiological data can only be explained by the presence of multiple aetiological factors, including analgesics, society stress, cigarette smoking, Helicobacter pylori, dietary factors, and genetic factors. Three lines of evidence support a genetic role: family studies, twin studies and blood group studies. Family aggregation occurs more commonly in patients with early-onset (< 30 yr) of symptoms. Blood group O prevalence is more associated with late-onset of symptoms. Other genetic markers include nonsecretor status, HLA antigens, phenylthiocarbamide taste sensitivity, and alpha-1-antitrypsin. Genetic syndromes such as MEN I also support a genetic role and give insight into pathogenetic mechanisms. The best physiological marker is still hyperpepsinogenemia I, which is transmitted by autosomal dominance, despite recent report of lower serum pepsinogen 1 after healing of Helicobacter pylori associated gastritis.
在世纪之交,十二指肠溃疡从罕见疾病发展到影响10%的男性一生,随后在一些国家如英国发病率下降,在另一些国家如德国趋于平稳,而在其他一些地区如香港仍持续上升。每1000人口的年发病率在日本约为1例,在挪威为1.5例,在美国为1.8例,在苏格兰为2.7例,而且在许多国家内部如澳大利亚、中国和印度,以及在不同种族之间如在美国白人患病率高于黑人,在印度华人患病率高于爪哇人,发病率也存在差异。溃疡发病率在冬季较高,这似乎是普遍现象,在寒冷和温暖的国家都是如此。大多数地区报告近几十年来老年人溃疡发病率上升。男女比例在不同地区也有所不同,例如在美国为1:1,在印度为18:1,并且随着时间变化,如在美国过去二十年中从2:1变为1:1,十二指肠溃疡与胃溃疡的比例在不同地方差异很大,例如在日本为0.8,在非洲为19:1,在印度为32:1。安慰剂治愈率在不同地区也有所不同,从菲律宾的5%到墨西哥的78%。这些流行病学数据只能通过多种病因因素的存在来解释,包括镇痛药、社会压力、吸烟、幽门螺杆菌、饮食因素和遗传因素。有三条证据支持遗传因素的作用:家族研究、双胞胎研究和血型研究。家族聚集现象在症状早发(<30岁)的患者中更为常见。血型O的患病率与症状晚发更相关。其他遗传标记包括非分泌状态、HLA抗原、苯硫脲味觉敏感性和α-1-抗胰蛋白酶。诸如MEN I等遗传综合征也支持遗传因素的作用,并有助于深入了解发病机制。最好的生理标志物仍然是高胃蛋白酶原I血症,它由常染色体显性遗传传递,尽管最近有报告称幽门螺杆菌相关性胃炎治愈后血清胃蛋白酶原1降低。